Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas. (Q33618421)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

title

Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

author name string

Loretta De Chiara

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Ana M Rodríguez-Piñeiro

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

Francisco J Rodríguez-Berrocal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

David Martínez-Ares

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

María Páez de la Cadena

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

language of work or name

English

0 references

publication date

28 June 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

page(s)

333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

Soluble CD26 levels and its association to epidemiologic parameters in a sample population

6 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

A new multitest correction (SGoF) that increases its statistical power when increasing the number of tests

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Serum leptin, adiponectin, and resistin concentration in colorectal adenoma and carcinoma (CC) patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Colorectal cancer and dysplasia in inflammatory bowel disease

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Cancer screening in the United States, 2008: a review of current American Cancer Society guidelines and cancer screening issues

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Polyp miss rate determined by tandem colonoscopy: a systematic review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Identification of nicotinamide N-methyltransferase as a novel serum tumor marker for colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Clinical interest of the combined use of serum CD26 and alpha-L-fucosidase in the early diagnosis of colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Seprase complexes in cellular invasiveness.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

The multifunctional or moonlighting protein CD26/DPPIV.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Preoperative serum CD26 levels: diagnostic efficiency and predictive value for colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Randomised controlled trial of faecal-occult-blood screening for colorectal cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

A comparison of fecal occult-blood tests for colorectal-cancer screening

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Colorectal cancer screening: a comparison of 35 initiatives in 17 countries.

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-333

Discovery and identification of alpha-defensins as low abundant, tumor-derived serum markers in colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-333

Serum sulfatase activity is more elevated in colonic adenomas than cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-333

Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-333

One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-333

Initial analyses of colon cancer-specific antigen (CCSA)-3 and CCSA-4 as colorectal cancer-associated serum markers

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2912863

Can patients at high risk for significant colorectal neoplasms and having normal quantitative faecal occult blood test postpone elective colonoscopy?

30 October 2018

1 reference

12 December 2020

Population colorectal cancer screening with fecal occult blood test

1 reference

12 December 2020

A prospective, controlled assessment of factors influencing acceptance of screening colonoscopy

1 reference

12 December 2020

Screening for colorectal cancer in Chinese: comparison of fecal occult blood test, flexible sigmoidoscopy, and colonoscopy

1 reference

12 December 2020

Fecal DNA versus fecal occult blood for colorectal-cancer screening in an average-risk population

1 reference

12 December 2020

How much can current interventions reduce colorectal cancer mortality in the U.S.?

1 reference

12 December 2020

Value of the serum alpha-L-fucosidase activity in the diagnosis of colorectal cancer

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-10-333

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

6 February 2020

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20584285%20AND%20SRC:MED&resulttype=core&format=json

6 February 2020

PubMed publication ID

20584285

1 reference